LGALS4
LGALS4 (galectin 4, also known as GAL4) is a member of the galectin family of beta-galactoside-binding proteins. It binds lactose and a related range of sugars, and may contribute to the assembly of adherens junctions. Browse Assay Genie's current range of LGALS4 research reagents below, or read on for the biology behind the target.
LGALS4 encodes galectin-4, a galectin that binds lactose and a related range of sugars. Galectins as a group are beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. For galectin-4 specifically, UniProt notes that it may be involved in the assembly of adherens junctions, the cell-cell contacts that hold epithelial cells together. This function is described as possible rather than established, so it is best treated as a working hypothesis in experimental design.
The human LGALS4 gene sits at 19q13.2 and encodes a protein of 323 amino acids. The mouse and rat orthologues are both named Lgals4, which allows comparable studies of the LGALS4 gene and its protein product across these species. Expression of the gene is restricted to the small intestine, colon and rectum, so the protein is of particular interest in studies of the gut epithelium. Subcellular localisation is not annotated in UniProt, so it should be established experimentally for the system under study.
The gene is underexpressed in colorectal cancer, according to the NCBI Gene summary, which links galectin-4 to research on intestinal tumour biology. HGNC classifies the gene within the Galectins group. Its approved name is galectin 4, and its previous name was lectin, galactoside-binding, soluble, 4. GAL4 is a recognised alias, and the protein is also called Galectin-4. Other galectin genes with related names include LGALS2, LGALS8, LGALS12, LGALS13 and LGALS14.
LGALS4 is underexpressed in colorectal cancer, making it a candidate marker for studying changes in intestinal epithelial gene expression during tumour development.
Expression is restricted to the small intestine, colon and rectum, so galectin-4 is a useful target for studying gut-specific lectin function.
Galectin-4 may be involved in assembling adherens junctions, which makes it relevant to work on epithelial cell-cell contacts.
As a galectin that binds lactose and related sugars, it is relevant to studies of beta-galactoside recognition and cell-matrix interactions.
LGALS4 encodes galectin-4, a lectin that binds lactose and a related range of sugars. UniProt reports that it may be involved in the assembly of adherens junctions. Galectins in general are implicated in modulating cell-cell and cell-matrix interactions.
LGALS4 is the approved symbol for galectin 4. The protein is also called Galectin-4, and GAL4 is a recognised alias. The earlier HGNC name was lectin, galactoside-binding, soluble, 4. Searching under any of these names should find the same target.
NCBI Gene reports that LGALS4 is underexpressed in colorectal cancer, and that its expression is restricted to the small intestine, colon and rectum. Mouse and rat both have an orthologue named Lgals4; check the datasheet of any product for its validated reactivity.
Other members of the galectin family, which share beta-galactoside-binding activity with LGALS4.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P56470; product specifications from Assay Genie datasheets.